Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00461331 · ClinicalTrials.gov registry record · Phase 4
Comparison of Insulins Aspart and Lispro in Insulin Pumps
A Phase 4 study, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00461331 is a Phase 4 study that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 20 participants.
The verdict
NCT00461331, a Phase 4 study, has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the glycemic control between insulins aspart and lispro 48 to 100 hours after pump infusion line change in subjects with type 1 using diabetes using an insulin pump.
Interventions
- DRUG Insulin Lispro
- DRUG Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00461331
The ClinicalTrials.gov registry entry for NCT00461331 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University Health Sciences Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin Lispro is the first listed.
NCT00461331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00461331 about?
NCT00461331 is a clinical study titled "Comparison of Insulins Aspart and Lispro in Insulin Pumps". The purpose of the study is to compare the glycemic control between insulins aspart and lispro 48 to 100 hours after pump infusion line change in subjects with type 1 using diabetes using an insulin pump.
What is the current status of trial NCT00461331?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00461331?
The interventions under investigation include: Insulin Lispro (DRUG), Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT00461331?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.